✦ LIBER ✦

Phase II study of cisplatin (CDDP) and 5-fluorouracil (5-FU) with concurrent hyperfractionated thoracic radiotherapy (HFTRT) for locally advanced non-small-cell lung cancer (LA-NSCLC): A preliminary report from the Okayama Lung Cancer Study Group

✍ Scribed by Segawa, Y; Ueoka, H; Kiura, K; Sakae, K; Hiraki, Y; Takigawa, N; Eguchi, K; Hiraki, S; Harada, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II study of docetaxel (TXT) an

✍ Matsuo, K; Hiraki, S; Watanabe, Y; Ueoka, H; Kiura, K; Moritaka, T; Kamei, H; Eg 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Phase I study of irinotecan (CPT-11) and

✍ Nakamura, Y; Fukuda, M; Fukuda, Mi; Soda, H; Ichiki, M; Takatani, H; Kanda, T; K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Chemotherapy with 5-fluorouracil (5-FU)

✍ Frederick Richards Ii; David J. Perry; Maria Goutsou; Caron Modeas; Elaine Muchm 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

Phase I/II study of docetaxel and cispla

✍ Kiura, K; Ueoka, H; Segawa, Y; Tabata, M; Kamei, H; Takigawa, N; Hiraki, S; Wata 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

PD-049 A phase II study of induction CDD

✍ Shibata, K.; Kasahara, K.; Sone, T.; Kita, T.; Nishitsuji, M.; Shirasaki, H.; Ki 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Phase I/II study of daily carboplatin, 5

✍ Yoshizawa, H; Tanaka, J; Kagamu, H; Maruyama, Y; Miyao, H; Ito, K; Sato, T; Iwas 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 95 KB